# Alpha Modus Holdings, Inc.: financial statements, quarterly

AMOD · Nasdaq · CIK 1862463 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amod.md) · [Financials](/companies/amod/financials.md) · [Filings](/companies/amod/filings.md) · [Insiders](/companies/amod/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amod/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $k | not reported | not reported | [76.5](/filings/0001641172-25-010849.md) | [48.1](/filings/0001641172-25-023068.md) | [161](/filings/0001493152-25-023547.md) | [110 d](/filings/0001493152-26-014230.md) | [1,067](/filings/0001493152-26-023186.md) | [623](/filings/0001493152-26-038220.md) | [685](/filings/0001493152-25-023547.md) | [784 d](/filings/0001493152-26-014230.md) | [997](/filings/0001493152-26-023186.md) | [1,010](/filings/0001493152-26-038220.md) |
| Operating income | $k | [(575)](/filings/0001213900-24-099383.md) | [1,356 d](/filings/0001641172-25-004768.md) | [(191)](/filings/0001641172-25-010849.md) | [(121)](/filings/0001641172-25-023068.md) | [(286)](/filings/0001493152-25-023547.md) | [(237) d](/filings/0001493152-26-014230.md) | [(1,359)](/filings/0001493152-26-023186.md) | [(1,149)](/filings/0001493152-26-038220.md) | [(1,218)](/filings/0001493152-25-023547.md) | [(1,518) d](/filings/0001493152-26-014230.md) | [(3,807)](/filings/0001493152-26-023186.md) | [(2,560)](/filings/0001493152-26-038220.md) |
| Interest expense | $k | not reported | not reported | [31.8](/filings/0001641172-25-010849.md) | [66.5](/filings/0001641172-25-023068.md) | [29.6](/filings/0001493152-25-023547.md) | [(113) d](/filings/0001493152-26-014230.md) | [222](/filings/0001493152-26-023186.md) | [484](/filings/0001493152-26-038220.md) | [2,817](/filings/0001493152-25-023547.md) | [458 d](/filings/0001493152-26-014230.md) | [591](/filings/0001493152-26-023186.md) | [402](/filings/0001493152-26-038220.md) |
| Income tax | $k | [51.7](/filings/0001213900-24-099383.md) | [(21.8) d](/filings/0001213900-24-042933.md) | [21.4](/filings/0001213900-24-050124.md) | [25.8](/filings/0001213900-24-071836.md) | [11.8](/filings/0001213900-24-099383.md) | [(58.7) d](/filings/0001493152-26-014230.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(228)](/filings/0001213900-24-099383.md) | [(786) d](/filings/0001641172-25-004768.md) | [(223)](/filings/0001493152-25-023547.md) | [(187)](/filings/0001493152-25-023547.md) | [(316)](/filings/0001493152-25-023547.md) | [4,829 d](/filings/0001493152-26-014230.md) | [(308)](/filings/0001493152-26-038220.md) | [(2,787)](/filings/0001493152-26-038220.md) | [(4,260)](/filings/0001493152-25-023547.md) | [(666) d](/filings/0001493152-26-014230.md) | [(4,021)](/filings/0001493152-26-038220.md) | [(2,149)](/filings/0001493152-26-038220.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.06)](/filings/0001641172-25-010849.md) | [(0.03)](/filings/0001641172-25-023068.md) | [(0.05)](/filings/0001493152-25-023547.md) | not reported | [(0.02)](/filings/0001493152-26-023186.md) | [(8.72)](/filings/0001493152-26-038220.md) | [(0.10)](/filings/0001493152-25-023547.md) | not reported | [(0.08)](/filings/0001493152-26-023186.md) | [(1.02)](/filings/0001493152-26-038220.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.06)](/filings/0001641172-25-010849.md) | [(0.03)](/filings/0001641172-25-023068.md) | [(0.05)](/filings/0001493152-25-023547.md) | not reported | [(0.02)](/filings/0001493152-26-023186.md) | [(8.72)](/filings/0001493152-26-038220.md) | [(0.10)](/filings/0001493152-25-023547.md) | not reported | [(0.08)](/filings/0001493152-26-023186.md) | [(1.02)](/filings/0001493152-26-038220.md) |

- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001213900-24-099383.md) | [0.1](/filings/0001213900-24-050124.md) | [0.1](/filings/0001213900-24-071836.md) | [0.0](/filings/0001213900-24-099383.md) | [0.7](/filings/0001493152-26-014230.md) | [0.1](/filings/0001641172-25-010849.md) | [0.1](/filings/0001641172-25-023068.md) | [0.1](/filings/0001493152-25-023547.md) | [0.1](/filings/0001493152-26-038220.md) | [0.0](/filings/0001493152-26-023186.md) | [2.0](/filings/0001493152-26-038220.md) |
| Current assets | $m | [1.4](/filings/0001213900-23-087203.md) | [0.1](/filings/0001641172-25-004768.md) | [1.1](/filings/0001213900-24-050124.md) | [0.6](/filings/0001213900-24-071836.md) | [0.4](/filings/0001213900-24-099383.md) | [1.7](/filings/0001493152-26-014230.md) | [0.9](/filings/0001641172-25-010849.md) | [0.7](/filings/0001641172-25-023068.md) | [0.4](/filings/0001493152-25-023547.md) | [0.8](/filings/0001493152-26-038220.md) | [2.5](/filings/0001493152-26-023186.md) | [3.3](/filings/0001493152-26-038220.md) |
| Total assets | $m | [11.9](/filings/0001213900-23-087203.md) | [0.1](/filings/0001641172-25-004768.md) | [12.5](/filings/0001213900-24-050124.md) | [6.5](/filings/0001213900-24-071836.md) | [6.3](/filings/0001213900-24-099383.md) | [1.7](/filings/0001493152-26-014230.md) | [0.9](/filings/0001641172-25-010849.md) | [0.7](/filings/0001641172-25-023068.md) | [0.4](/filings/0001493152-25-023547.md) | [0.8](/filings/0001493152-26-038220.md) | [2.6](/filings/0001493152-26-023186.md) | [3.4](/filings/0001493152-26-038220.md) |
| Current liabilities | $m | [4.6](/filings/0001213900-23-087203.md) | [1.1](/filings/0001641172-25-004768.md) | [5.8](/filings/0001213900-24-050124.md) | [5.8](/filings/0001213900-24-071836.md) | [5.7](/filings/0001213900-24-099383.md) | [7.6](/filings/0001493152-26-014230.md) | [6.9](/filings/0001641172-25-010849.md) | [10.0](/filings/0001641172-25-023068.md) | [10.8](/filings/0001493152-25-023547.md) | [8.6](/filings/0001493152-26-038220.md) | [8.1](/filings/0001493152-26-023186.md) | [9.5](/filings/0001493152-26-038220.md) |
| Total liabilities | $m | [11.9](/filings/0001213900-23-087203.md) | [1.1](/filings/0001641172-25-004768.md) | [13.1](/filings/0001213900-24-050124.md) | [13.3](/filings/0001213900-24-071836.md) | [13.3](/filings/0001213900-24-099383.md) | [10.5](/filings/0001493152-26-014230.md) | [9.9](/filings/0001641172-25-010849.md) | [10.0](/filings/0001641172-25-023068.md) | [10.8](/filings/0001493152-25-023547.md) | [8.6](/filings/0001493152-26-038220.md) | [8.1](/filings/0001493152-26-023186.md) | [9.5](/filings/0001493152-26-038220.md) |
| Shareholders' equity | $m | [(11.3)](/filings/0001213900-24-099383.md) | [(1.0)](/filings/0001493152-26-014230.md) | [(1.1)](/filings/0001493152-25-023547.md) | [(1.3)](/filings/0001493152-25-023547.md) | [(1.6)](/filings/0001493152-25-023547.md) | [(80.6)](/filings/0001493152-26-038220.md) | [(80.9)](/filings/0001493152-26-038220.md) | [(50.5)](/filings/0001493152-26-038220.md) | [(51.6)](/filings/0001493152-25-023547.md) | [(49.0)](/filings/0001493152-26-038220.md) | [(46.6)](/filings/0001493152-26-038220.md) | [(6.1)](/filings/0001493152-26-038220.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.4) d](/filings/0001213900-24-099383.md) | [1.8 d](/filings/0001641172-25-004768.md) | [(0.2)](/filings/0001641172-25-010849.md) | [(0.1) d](/filings/0001641172-25-023068.md) | [(0.3) d](/filings/0001493152-25-023547.md) | [(1.1) d](/filings/0001493152-26-014230.md) | [(0.6)](/filings/0001493152-26-023186.md) | [(0.5) d](/filings/0001493152-26-038220.md) | [(0.9) d](/filings/0001493152-25-023547.md) | [(1.2) d](/filings/0001493152-26-014230.md) | [(1.5)](/filings/0001493152-26-023186.md) | [(0.9) d](/filings/0001493152-26-038220.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001493152-25-023547.md) | [0.0 d](/filings/0001493152-26-014230.md) | [0.1](/filings/0001493152-26-023186.md) | [0.0 d](/filings/0001493152-26-038220.md) |
| Share repurchases | $m | [19.2 d](/filings/0001213900-24-099383.md) | [(235) d](/filings/0001641172-25-004768.md) | not reported | not reported | [0.0 d](/filings/0001213900-24-099383.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.5](/filings/0001193125-23-159821.md) | [3.5](/filings/0001641172-25-010849.md) | [5.5](/filings/0001641172-25-023068.md) | [6.1](/filings/0001493152-25-023547.md) | [12.5](/filings/0001493152-26-023186.md) | [0.3](/filings/0001493152-26-038220.md) | [41.4](/filings/0001493152-25-023547.md) | [47.9](/filings/0001493152-26-023186.md) | [2.1](/filings/0001493152-26-038220.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,966,818 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038220.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.